Literatur
-
1
Warkentin T E, Chong B H, Greinacher A.
heparin-induced thrombocytopenia: towards consensus.
Thromb Haemost.
1998;
79
1-7
-
2
Warkentin T E, Levine M N, Hirsh J, Horsewood P, Roberts R S, Tech M, Gent M, Kelton J G.
Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin.
New Engl J Med.
1995;
332
1330-1335
-
3
Glusa E, Markwardt F.
Platelet function in recombinant hirudin-anticoagulated blood.
Hemostasis.
1990;
20
112-118
-
4
Markwardt F.
Hirudin: The promising antithrombotic.
Cardiovasculary Drug Review.
1992;
10
211-232
-
5
Nowak G, Bucha E, Gööck T, Thieler H, Markwardt F.
Pharmacology of r-hirudin in renal impairment.
Thromb Res.
1992;
66
707-715
-
6
Eichler P, Olbrich K, Pötzsch B, Greinacher A.
Anti-hirudin antibodies in patients treated with recombinant hirudin for more than five days, a prospective study (abstract).
Thromb Haemost.
1997;
Suppl
PS 2014
-
7
Song X H, Huhle G, Wang L C, Hoffmann U, Harenberg J.
Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin.
Circulation.
1999;
100
1528-1532
-
8
Harenberg J, Hoffmann U, Huhle G, Song X H, Wang L C.
Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin.
Br J Haematol.
2000;
108
528-530
-
9
Greinacher A.
Rekombinantes Hirudin zur weiteren Antikoagulation bei Patienten mit Heparin-induzierter Thrombozytopenie.
Hämostaseologie.
1999;
19
19-29
-
10
Meulemann D G.
Orgaran (Org 10172): its pharmacological profile in experimental models.
Haemostasis.
1989;
22
58-65
-
11 Bergqvist D, Lindblad B, Mätzsch T. Glykosaminoglykans in prophylaxis against venous thromboembolism. In: Lane DA, Björk I, Laindahl U (Eds.) Heparin and Related Polysaccharides. New York; Plenum Press 1992: 259-274
-
12
Gordon D L, Libhardt R, Adams H P.
Low molecular weight heparins and heparinoids and their use in acute or progressing ischemic stroke.
Clin Neuropharmacol.
1990;
13
522-543
-
13 Mangani H. Orgaran (Danaparoid-sodium) use in the syndrome of heparin-induced thrombocytopenia. Proceedings of a workshop held in London, 1992. November 1. London; Platelets 1992: 74-81
-
14
Harenberg J, Zimmermann R, Schwarz F, Kübler W.
Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
Lancet.
1983;
1
986-987
-
15
Chong B H, Gallus A S, Cade J F, Magnani H, Manoharan A, Oldmeadow M, Arthur C, Richard K, Gallo J, Lloyd J, Seshadri P, Chesterman N.
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis - a clinical outcome study.
Thromb Haemost.
2001;
86
1170-1175
Prof. Dr. Job Harenberg
4. Medizinische Klinik, Universitätsklinikum Mannheim
Theodor-Kutzer-Ufer
68168 Mannheim
